Dihydroquinazolinone analogues

US9199988B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Christian Alan Paul Smethurst · Wien, AT
• Harald Engelhardt · Ebreichsdorf, AT
• Davide Gianni · Wien, AT
• Ulrich Reiser · Wien, AT

Key dates

• Filing date: Mar 26, 2014
• Grant date: Dec 1, 2015
• Expiry date: Mar 26, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention encompasses compounds of general formula (I)wherein the groups R1 to R4 and A1 to A5 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.